Sunday, May 20, 2018

FDA delays decision on first drug to prevent HIV

WASHINGTON — Federal health regulators have delayed a decision on whether to approve the first pill shown to prevent HIV infection, the drug's manufacturer says.

Gilead Sciences disclosed Friday that the Food and Drug Administration will take three more months to review its application for Truvada, after the company submitted additional materials to the agency earlier this month.

In May, a panel of experts recommended approval of the daily pill for healthy people who are at high risk of contracting HIV, including gay and bisexual men. The vote was nonbinding, though the FDA often follows the group's advice.

Gilead said it submitted updated information on its planned safety materials for patients and doctors using the drug. The FDA typically extends its reviews after receiving such information.

The FDA is now expected to rule by Sept. 14, the company said in a statement.

Gilead Sciences Inc., based in Foster City, Calif., has marketed Truvada since 2004 as a treatment for people who are infected with the virus. The medication is a combination of two older HIV drugs, Emtriva and Viread.

Truvada made headlines in 2010, when government researchers showed it could actually prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42 percent, when accompanied by condoms and counseling. Last year another study found that Truvada reduced infection by 75 percent in heterosexual couples in which one partner was infected with HIV and the other was not.

An estimated 1.2 million Americans have HIV, which develops into AIDS unless treated with antiviral drugs.

Because Truvada is on the market to manage HIV, some doctors prescribe it as a preventive measure. FDA approval would allow Gilead Sciences to formally market its drug for that use.

Comments

Here is the latest Florida sports news from The Associated Press

Here is the latest Florida sports news from The Associated Press
Updated: 1 hour ago

AP Top News at 3:13 a.m. EDT

AP Top News at 3:13 a.m. EDT
Updated: 1 hour ago
Iraq's al-Sadr, promising reform, is constrained by Iran

Iraq's al-Sadr, promising reform, is constrained by Iran

Iraq's Muqtada al-Sadr, the maverick Shiite cleric whose political coalition beat out Iran's favored candidates to come in first in national elections, says he wants to form a government that puts Iraqis first
Updated: 1 hour ago
Iraq's al-Sadr, promising reform, is constrained by Iran

Iraq's al-Sadr, promising reform, is constrained by Iran

Iraq's Muqtada al-Sadr, the maverick Shiite cleric whose political coalition beat out Iran's favored candidates to come in first in national elections, says he wants to form a government that puts Iraqis first
Updated: 1 hour ago
British royal family thanks those who celebrated wedding

British royal family thanks those who celebrated wedding

The royal family has thanked people who attended or watched the wedding of Prince Harry and Meghan Markle
Updated: 2 hours ago
Rays hang on to beat Angels 5-3 behind Robertson slam, get back to .500

Rays hang on to beat Angels 5-3 behind Robertson slam, get back to .500

ANAHEIM, Calif. – Playing .500 ball is obviously no goal, and the Rays certainly know that.But given where they came from, that terrible 1-8 start that oozed into 3-12 and 4-13, climbing back to the respectability of .500 would be an accomplish...
Updated: 2 hours ago
LEADING OFF: Ohtani takes mound, Romo starts again for Rays

LEADING OFF: Ohtani takes mound, Romo starts again for Rays

LEADING OFF: Angels rookie Shohei Ohtani starts vs Rays - who'll start reliever Sergio Romo for second straight game
Updated: 2 hours ago
Rays plan to have reliever Romo start 2nd straight day

Rays plan to have reliever Romo start 2nd straight day

Tampa Bay Rays reliever Sergio Romo will start for the second consecutive day in the finale of a four-game series against the Los Angeles Angels on Sunday, Rays manager Kevin Cash said following a 5-3 win on Saturday night
Updated: 2 hours ago
Small clubs cross fingers for World Cup windfalls

Small clubs cross fingers for World Cup windfalls

Not all of the money that will change hands after the World Cup, when clubs trade players who distinguish themselves on football's biggest stage, will line the pockets of selling clubs, agents and the players themselves
Updated: 3 hours ago
Small clubs cross fingers for World Cup windfalls

Small clubs cross fingers for World Cup windfalls

Not all of the money that will change hands after the World Cup, when clubs trade players who distinguish themselves on football's biggest stage, will line the pockets of selling clubs, agents and the players themselves
Updated: 3 hours ago